15
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Acceptance Limits for Bioequivalence Studies

Pages 127-137 | Published online: 02 Jul 2009

References

  • Rhodes C. T. Clinical Research and Drug Regulatory Affairs 1994; 11: 181–184
  • Benet L., Goyan J. Pharmacotherapy 1995; 15: 433–440
  • Rhodes C. T. Clinical Research and Drug Regulatory Affairs 1995; 12: 267–272
  • Rosenbaum S. E., Lam J. Drug Development and Industrial Pharmacy 1997; 22: 337–344
  • CFR. 320–33
  • James Benson S. Acting Commissioner of Food and Drugs. 1 October, 1990, Letter from
  • FDA Compliance Program Guide Manual. 15 August, 1994, published
  • SUPAC Guidelines. November, 1995, published
  • Rhodes C. T. Chapter on Bioequivalence. Drugs for Clinical Trials, Monkhouse, Rhodes. Marcel Dekker. 1997
  • Rosenbaum S. E.A., Carter A., Dudley M. N. Drug Development and Industrial Pharmacy 1995; 9: 1115–1139

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.